Last reviewed · How we verify

NCT06031883: TIVA

Efficacy of Adding Low Dose Ketamine or Fentanyl to Propofol-dexmedetomidine as Total Intravenous Anesthesia

Completed Phase 1, PHASE2 Last updated 30 July 2025
What this trial tests

Phase 1, PHASE2 trial testing Ketamine in Patients Undergoing Elective Craniotomy in 40 participants. Completed in 5 March 2025.

Timeline
1 February 2023
Primary endpoint
1 December 2024
5 March 2025

Quick facts

Lead sponsorMinia University
PhasePhase 1, PHASE2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment40
Start date1 February 2023
Primary completion1 December 2024
Estimated completion5 March 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 18 to 70, any sex, with Patients Undergoing Elective Craniotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Efficacy of adding low dose ketamine or fentanyl to propofol-dexmedetomidine as total intravenous anesthesia for patients undergoing craniotomy in supra tentorial brain tumor

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ketamine

Trials testing the same drug.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing